88 ANB032, a novel BTLA agonist monoclonal antibody, inhibits T cell proliferation, reduces inflammatory cytokines, and down modulates BTLA expression on circulating T and B cells
Authors:
- K. LuuKLK. Luu
- B. RandazzoBRB. Randazzo
- E. HareEHE. Hare
- M. HsuMHM. Hsu
- C. HainesCHC. Haines
- M. DahlMDM. Dahl
- C. SibleyCSC. Sibley
- P. LizzulPLP. Lizzul
- 6 November 2023
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (11) , S347